好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Greater Childhood Adversity and Allostatic Load Biomarkers Among Pediatric Onset vs. Adult Onset Multiple Sclerosis
Health Care Disparities
P5 - Poster Session 5 (5:30 PM-6:30 PM)
4-006

To compare childhood neighborhood environment, biomarkers of allostatic load (AL), and current health insurance among pediatric onset MS (POMS) and adult onset MS (AOMS) patients.

Adversity can occur at the individual, family, and neighborhood levels. These chronic life stressors can trigger a physiologic stress response with downstream effects on the immune system, brain, and overall health. Allostatic load (AL) describes the wear and tear of stress on the body and some AL biomarkers can be measured with routine laboratory tests.

30 POMS and 30 AOMS participants (all young adults, age range 18-35 years) were consecutively recruited to the study during their routine MS clinic visit (seeing providers who accept the same health insurances). Self-report measures and serum samples were collected. The Area Deprivation Index (ADI), a measure of neighborhood adversity, was determined based on zip codes for childhood and current residence. Serum biomarkers were transformed to z-scores using age-normative values from NHANES database.

POMS vs. AOMS groups had similar MS disease duration: 6.09 + 2.90 vs. 6.16 + 3.53 years. Among POMS vs. AOMS, those self-reporting as white was lower: 43.3% vs. 56.7% while more participants self-reported as black 30.0% vs. 23.3%. POMS vs. AOMS were more often on public insurance (56.7% vs. 20%, p=.003) as opposed to private insurance. POMS vs. AOMS had a trend for greater childhood ADI (4.38 vs. 3.48, p=.054) but did not differ on current ADI. Overall, POMS vs. AOMS young adults had higher AL biomarkers of LDL (p=.004) and total cholesterol (p=.014). Blood pressure, triglycerides, and C-reactive protein levels were also elevated.

POMS vs. AOMS participants were more likely to be exposed to disadvantaged neighborhoods during childhood, were more frequently on public insurance and exhibit worse markers of increased AL. Better understanding is needed regarding how childhood adversity might affect later MS disease expression.

Authors/Disclosures
Kimberly O'Neill, MD
PRESENTER
Dr. O'Neill has nothing to disclose.
Shayna Pehel Ms. Pehel has nothing to disclose.
Nadine Azmy No disclosure on file
Steven Friedman Steven Friedman has nothing to disclose.
Jiyuan Hu (NYU Grossman School of Medicine) Jiyuan Hu has nothing to disclose.
Matthew Lustberg No disclosure on file
Anna Sosa Anna Sosa has nothing to disclose.
Leigh E. Charvet, PhD (NYU Langone) Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Lauren B. Krupp, MD, FAAN (NYU Langone Medical Center) Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.